Please use this identifier to cite or link to this item:
Title: Discontinuation of metformin in the setting of coronary angiography: clinical uncertainty amongst physicians reflecting a poor evidence base.
Authors: Maznyczka, A
Myat, A
Gershlick, A
First Published: Jan-2012
Citation: EUROINTERVENTION, 2012, 7 (9), pp. 1103-1110
Abstract: Metformin is widely prescribed for the treatment of type 2 diabetes mellitus and is associated with a reduction in diabetes-induced cardiovascular morbidity and mortality. Concerns about metformin-associated lactic acidosis (M-ALA) in patients undergoing contrast-based angiographic procedures have led to the development and publication of a number of guidelines to improve the management of this patient cohort.
DOI Link: 10.4244/EIJV7I9A175
eISSN: 1969-6213
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cardiovascular Sciences

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.